Sovereign gold bonds open for subscription on October 12: Here's what you need to know

The issue date for the seventh tranche of sovereign gold bonds is October 20. The government will conduct issuance of the bonds in five more tranches during the FY21.

The Reserve Bank of India (RBI) has fixed the issue price of the seventh tranche of sovereign gold bonds (SGBs) at Rs 5,051 per gram. The subscription date for the series is October 12-16.

The issue date for the seventh tranche is October 20. The government will conduct issuance of the bonds in five more tranches during the FY21.

SGBs, first introduced in 2015, are government securities denominated in grams of gold. They are issued by the central bank on behalf of the central government.

On October 7, gold prices fell by Rs 757 to Rs 50,287 per 10 gram in the Mumbai retail market.

Here's all you need to need to know about SGBs:

> They are issued at an interest rate of 2.5 percent, which is payable on a half-yearly basis, for a tenor of eight years. There is no capital gains tax charged on redemption of SGBs after maturity.

> The minimum investment is one gram, while the maximum is 4 kg for individuals, 4 kg for Hindu undivided families (HUFs) and 20 kg for trusts and similar entities.

> The government announced six tranches in April for the 2020-21 fiscal year, and six more tranches in October.

> SGBs can be purchased at scheduled commercial banks (except small finance banks and payment banks), Stock Holding Corporation of India (SHCIL), designated post offices, and recognised stock exchanges such as the NSE and the BSE.

> Those who apply digitally get a discount of Rs 50 per gram.

Here are the subscription dates for the remaining tranches:

> 2020-21 Series VIII: November 9 - 13

> 2020-21 Series IX: December 28, 2020-January 1, 2021

> 2020-21 Series X: January 11-15

> 2020-21 Series XI February 1- 5

> 2020-21 Series XII March 1- 5

Comments

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...

SD Solutions

Search This Blog